Manufacturers That Are Nearly MDR-Ready May Lose Their Advantage Unless Audits Can Take Place Virtually
Industry is urgently seeking certainty over EU virtual notified body audits, fearing that companies now at the front of the MDR line might be sent to the back and have to reapply under the existing directives.
You may also be interested in...
The speed to market for innovative products in the EU has been hampered because of the time it has taken to set up “expert panels” under the Medical Device Regulation. Will these products now make 26 May 2021 deadline?
Virtual notified body audits of medtech manufacturers are already taking place through necessity. Now there is guidance concerning if, when, where and how these audits should be carried out.
While it was obvious to those in the sector that the implementation of the EU IVD Regulation was heading for a disaster, this article looks at the facts and figures that helped sway the European Commission to propose new transition periods to better manage its implementation.